Cigna Group (CI) Stock Forecast & Price Target

Cigna Group
Bull Case

Here are some ways that investors could benefit from investing in The Cigna Group:

• The Cigna Group recently raised its full-year 2026 adjusted earnings per share outlook to at least $30.60, following a strong third quarter where actual EPS of $7.98 significantly beat the consensus estimate of $7.52, signaling robust operational performance and upward momentum in profitability.
• Management has set an ambitious long-term target of at least $45 in earnings per share by 2030, a goal that assumes the specialty business, which currently drives 37% of earnings, will grow to 40% of the total, providing a clear and aggressive growth trajectory for shareholders.
• The stock currently trades at $301.25, which represents a valuation discount relative to the broader market, with analysts noting the company trades at a modest 9x forward earnings multiple, offering a potential entry point for value-oriented investors seeking exposure to a growing healthcare services provider.
• The company is executing a significant capital return strategy, having reduced its share count by a fifth over the last five years and planning to deploy 20% to 25% of its projected $50 billion in cash flow from operations through 2030 toward share repurchases, which supports per-share value growth.
• Wall Street maintains a Moderate Buy consensus with a price target of $338.24, suggesting approximately 12% upside potential from the current price, as analysts recognize the company's ability to offset pharmacy headwinds with strong growth in its specialty and care delivery segments.